Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Physical Medicine and Rehabilitation for Complex Regional Pain Syndromes Treatment & Management

  • Author: Manish K Singh, MD; Chief Editor: Stephen Kishner, MD, MHA  more...
 
Updated: Mar 04, 2015
 

Rehabilitation Program

Physical Therapy

It is extremely important for patients with RSD to undergo a steady progression from gentle weight bearing to progressive, active weight bearing.[14] Gradual desensitization to increasing sensory stimuli also plays an important role. The altered processing in the CNS is typically reset by a gradual increase in normalized sensation. Other intervention should be offered to enable greater confidence and comfort when patients do not progress in a reasonable amount of time.

Physical therapy (PT),[15] in association with occupational therapy (OT), plays an important role in functional restoration. The goal is to increase strength and flexibility gradually, beginning with gentle gliding exercises. Patients usually are reluctant to participate in PT because of intense pain. A self-directed or therapist-directed PT program is important and should be individualized to each patient's needs and goals.

Patients with CRPS also may have myofascial pain syndrome. A study by Rashiq and Galer found that myofascial pain syndrome can be treated first, and if it is treated effectively, the entire syndrome may resolve.[16] Myofascial pain may be treated with modalities and techniques, such as massage and myofascial release.

Occupational Therapy

An analysis by Steverens and colleagues noted that occupational therapists are very important for initiating gentle, active measurements and preliminary desensitization techniques with patients who have RSD.[17]

Occupational therapists usually are responsible for introducing and maintaining a stress-loading program for patients with CRPS. This program involves active compression and distraction exercises that provide stimuli to the affected extremity without joint motion. The scrubbing technique requires use of a scrub brush. Scrubbing is performed by gradually increasing the weight on the patient's affected extremity as he/she scrubs in circles. Weight loading of the joints is completed with increasing weight as the scrubbing process continues.

The next part in this program involves a carrying technique. The patient is instructed to carry a weight (bag) in the affected extremity throughout the day, as tolerated. The patient should monitor his/her symptoms and keep a daily record to share with the therapist.

The stress-loading program usually is started as a home exercise program. The patient also can use desensitization techniques (eg, rubbing the skin, massage, tapping, vibration) to reduce sensitivity and pain.

Recreational Therapy

Recreational therapy can help the patient with chronic pain to take part in pleasurable activities that help to decrease pain. The patient finds enjoyment and socialization in previously lost or new recreational activities. Usually, patients with chronic pain are depressed. Recreational therapists may play an important role in the treatment process and enable the patient to become active.

Vocational therapy should be recommended and initiated early for all appropriate patients. Vocational therapy can provide work capacities and targeted work hardening, and the patient may return to gainful employment.

Next

Medical Issues/Complications

Therapeutic strategies include pharmacologic pain relief, sympatholytic interventions, and rehabilitation.[15]

  • All treatments should focus primarily on functional restoration. Use of drugs, sympathetic blocks, and psychotherapy helps to achieve good pain control during PT.
  • Early intervention is important. The key to successful treatment of RSD is recognition of symptoms in stage I or early in stage II. Physicians should be alert to signs and symptoms of RSD. When RSD is suspected, the treating physician should ensure that that the patient receives evaluation by a pain specialist or other clinician experienced in treating this condition.
  • The time between the start of RSD and clinic attendance may vary from several days to years.
  • Identifying any underlying disease (eg, fracture, sprain, radiculopathy) and tailoring specific management are important.
  • Johnston and Howell reported significant pain improvement after release and anterior transposition of the nerve. [18] Five patients had RSD, 3 cases of which resolved after nerve release. Careful evaluation with diagnostic local nerve blocks and other conservative measures should be tried before surgery is considered.
  • Sympathetic or somatic block, if performed, should be integrated into a good rehabilitation program.
Previous
Next

Surgical Intervention

Sympathetic blocks

For the upper extremity, a stellate (cervicothoracic) ganglion block is recommended. Bupivacaine is preferred over lidocaine because of its longer half-life. Not all patients experience pain relief after blocks.

Percutaneous lumbar sympathetic plexus catheter placement usually provides short-term pain relief in most patients and may have some long-term effect.

Bier block (intravenous regional block)

In 1974, the concept of intravenous regional guanethidine was introduced. Block with bretylium or reserpine has less profound effect than it does with guanethidine, which may last for 2-3 days.

A double-blind, randomized study was designed to compare the effectiveness of intravenous regional sympatholysis using guanethidine, reserpine, and normal saline; the study reported significant pain relief in all 3 groups. No significant differences were noted among the 3 groups in the degree of pain relief. The saline group's high rate of pain relief could be due partially to a mechanism of tourniquet-induced analgesia.

A small controlled, randomized, double-blinded, prospective study of intravenous regional block with lidocaine and ketorolac resulted in only short-term pain reduction in patients with CRPS of the lower extremity. Of the several parameters measured, only one outcome resulted in significant improvement; in the ketorolac group, one day of significant pain reduction was noted.[19]

Somatic block

Somatic block, consisting of continuous epidural infusion with different variants of brachial plexus blocks, includes an axillary, supraclavicular, or infraclavicular approach that may be useful.

Dorsal column stimulator

Localized extremity pain may be relieved by a dorsal column stimulator. A spinal cord stimulator (SCS) can be an effective treatment for the pain of RSD, including recurrent pain after ablative sympathectomy.

Kumar and colleagues note that the low morbidity associated with this procedure and its efficacy in patients with refractory pain related to RSD suggest that SCS is superior to ablative sympathectomy in the management of RSD.[20] Careful evaluation is recommended before patient selection.

A study by Geurts et al of spinal cord stimulation in RSD found the treatment to be an effective long-term strategy in 63% of patients. It also suggested that achievement of at least 50% mean pain relief 1 week after test stimulation predicts long-term treatment success. The study included 84 patients with an implanted SCS, with 41% of patients feeling at least 30% pain relief at 11-year follow-up and 63% of patients still using their device at 12-year follow-up.[21]

Intrathecal infusion

Careful selection of patients is needed, as follows:

  • Baclofen pump: According to van Hilten and coauthors, an intrathecal (IT) Baclofen pump may be useful for treatment of dystonia in patients with RSD [22]
  • Morphine pump: Intrathecal opioids should be considered carefully for chronic pain of nonmalignant origin
  • Intrathecal bupivacaine infusion: As noted in a study by Lundborg and colleagues, this approach may alleviate the refractory pain, but it does not affect other associated symptoms or the natural course of CRPS I [23]

Sympathectomy

This includes the following strategies:

  • Radiofrequency or cryoprobe lesioning: If a sympathetic block produces significant pain relief twice, denervation with radio frequency or a cryoprobe could provide long-term relief
  • Surgical sympathectomy: Endoscopic cervicothoracic sympathectomy could be an effective minimally invasive therapy for upper extremity RSD
  • Chemical sympathectomy

Amputations

Dielissen and colleagues reviewed cases of 28 patients with RSD who had amputations for intractable pain or recurrent infection or to improve residual function.[24] Only 2 patients were relieved of pain by amputation, and this number could not be predicted. RSD recurred in the stump, especially after amputation at a level that was not free of symptoms.

Previous
Next

Consultations

In CRPS, as in other chronic pain conditions, the high incidence of personality pathology, as noted by Monti and co-authors, may represent an exaggeration of maladaptive personality traits and coping styles resulting from chronic, intense pain.[25] Such pathology can be addressed with the help of the following:

  • Evaluation - An evaluation by a psychologist is appropriate to identify the stressor and to gather information about the distress of the patient. The evaluation should consist of a structural clinical interview and a personality measure (eg, Minnesota Multiphasic Personality Scale, Hopelessness Index).
  • Psychotherapist
  • Biofeedback and counseling
Previous
Next

Other Treatment

Management strategies in CRPS also include the following:

  • Transcutaneous electrical nerve stimulation (TENS): According to Hassenbusch and co-authors, peripheral nerve stimulation can provide good relief for RSD when the condition is limited to the distribution of 1 major nerve [26]
  • Ultrasonography
  • Superficial hot packs
  • A double-blind, prospective, multicenter trial of 416 patients by Zollinger and colleagues has shown that Vitamin C seems to reduce the prevalence of CRPS after wrist fracture. The authors recommended a daily dose of 500 mg for 50 days. [27]
  • Improvements in pain and bone density following intravenous administration of pamidronate, alendronate, or clodronate have been described in a few patients

A literature review and meta-analysis by Mbizvo et al indicated that placebo treatment is for the most part ineffective in patients with long-standing CRPS (ie, CRPS of 6 months or more). The study, which encompassed 18 trials (340 patients), found that although patients did demonstrate a significant placebo response during the first 15-30 minutes of treatment, at the other time periods in the analysis (1 week, 3-4 weeks, and 6 weeks or more), no significant response occurred.[28]

Previous
 
 
Contributor Information and Disclosures
Author

Manish K Singh, MD Assistant Professor, Department of Neurology, Teaching Faculty for Pain Management and Neurology Residency Program, Hahnemann University Hospital, Drexel College of Medicine; Medical Director, Neurology and Pain Management, Jersey Institute of Neuroscience

Manish K Singh, MD is a member of the following medical societies: American Academy of Neurology, American Academy of Pain Medicine, American Headache Society, American Association of Physicians of Indian Origin, American Medical Association, American Society of Regional Anesthesia and Pain Medicine

Disclosure: Nothing to disclose.

Coauthor(s)

Patrick M Foye, MD Director of Coccyx Pain Center, Professor and Interim Chair of Physical Medicine and Rehabilitation, Rutgers New Jersey Medical School; Co-Director of Musculoskeletal Fellowship, Co-Director of Back Pain Clinic, University Hospital

Patrick M Foye, MD is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation, International Spine Intervention Society, American Association of Neuromuscular and Electrodiagnostic Medicine, Association of Academic Physiatrists

Disclosure: Nothing to disclose.

Jashvant Patel, MBBS, MS, MD 

Jashvant Patel, MBBS, MS, MD is a member of the following medical societies: Alberta Medical Association, American Academy of Pain Medicine, American Academy of Physical Medicine and Rehabilitation, American Medical Association, American Society of Regional Anesthesia and Pain Medicine, Medical Society of the State of New York

Disclosure: Nothing to disclose.

John Grothusen, PhD Director of Quantitative Sensory and Autonomic Nervous System Laboratory, Associate Professor, Department of Neurology, Drexel University College of Medicine

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Patrick M Foye, MD Director of Coccyx Pain Center, Professor and Interim Chair of Physical Medicine and Rehabilitation, Rutgers New Jersey Medical School; Co-Director of Musculoskeletal Fellowship, Co-Director of Back Pain Clinic, University Hospital

Patrick M Foye, MD is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation, International Spine Intervention Society, American Association of Neuromuscular and Electrodiagnostic Medicine, Association of Academic Physiatrists

Disclosure: Nothing to disclose.

Chief Editor

Stephen Kishner, MD, MHA Professor of Clinical Medicine, Physical Medicine and Rehabilitation Residency Program Director, Louisiana State University School of Medicine in New Orleans

Stephen Kishner, MD, MHA is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation, American Association of Neuromuscular and Electrodiagnostic Medicine

Disclosure: Nothing to disclose.

Acknowledgements

Debra Ibrahim New York College of Osteopathic Medicine

Disclosure: Nothing to disclose.

Leia Rispoli Rutgers New Jersey Medical School

Disclosure: Nothing to disclose.

References
  1. Paice E. Reflex sympathetic dystrophy. BMJ. 1995 Jun 24. 310(6995):1645-8. [Medline]. [Full Text].

  2. Uceyler N, Eberle T, Rolke R, et al. Differential expression patterns of cytokines in complex regional pain syndrome. Pain. Sep 2007. [Medline].

  3. Wasner G, Heckmann K, Maier C, et al. Vascular abnormalities in acute reflex sympathetic dystrophy (CRPS I): complete inhibition of sympathetic nerve activity with recovery. Arch Neurol. 1999 May. 56(5):613-20. [Medline]. [Full Text].

  4. Kurvers HA, Jacobs MJ, Beuk RJ, et al. The spinal component to skin blood flow abnormalities in reflex sympathetic dystrophy. Arch Neurol. 1996 Jan. 53(1):58-65. [Medline].

  5. Blaes F, Tschernatsch M, Braeu ME, Matz O, Schmitz K, Nascimento D. Autoimmunity in complex-regional pain syndrome. Ann N Y Acad Sci. 2007 Jun. 1107:168-73. [Medline].

  6. Veldman PH, Reynen HM, Arntz IE, Goris RJ. Signs and symptoms of reflex sympathetic dystrophy: prospective study of 829 patients. Lancet. 1993 Oct 23. 342(8878):1012-6. [Medline].

  7. Maleki J, LeBel AA, Bennett GJ, et al. Patterns of spread in complex regional pain syndrome, type I (reflex sympathetic dystrophy). Pain. 2000 Dec 1. 88(3):259-66. [Medline].

  8. Peterlin BL, Rosso AL, Nair S, et al. Migraine may be a risk factor for the development of complex regional pain syndrome. Cephalalgia. 2009 Jul 9. [Medline].

  9. Werner R, Davidoff G, Jackson MD, et al. Factors affecting the sensitivity and specificity of the three-phase technetium bone scan in the diagnosis of reflex sympathetic dystrophy syndrome in the upper extremity. J Hand Surg [Am]. 1989 May. 14(3):520-3. [Medline].

  10. Kozin F, Soin JS, Ryan LM, et al. Bone scintigraphy in the reflex sympathetic dystrophy syndrome. Radiology. 1981 Feb. 138(2):437-43. [Medline]. [Full Text].

  11. Schürmann M, Zaspel J, Löhr P, et al. Imaging in early posttraumatic complex regional pain syndrome: a comparison of diagnostic methods. Clin J Pain. 2007 Jun. 23(5):449-57. [Medline].

  12. Bruehl S, Lubenow TR, Nath H, Ivankovich O. Validation of thermography in the diagnosis of reflex sympathetic dystrophy. Clin J Pain. 1996 Dec. 12(4):316-25. [Medline].

  13. Chelimsky TC, Low PA, Naessens JM, et al. Value of autonomic testing in reflex sympathetic dystrophy. Mayo Clin Proc. 1995 Nov. 70(11):1029-40. [Medline].

  14. Brunnekreef JJ, Oosterhof J, Wolff AP, et al. No impaired hemoglobin oxygenation in forearm muscles of patients with chronic CRPS-1. Clin J Pain. 2009 Jul-Aug. 25(6):513-9. [Medline].

  15. [Guideline] Harden RN, Oaklander AL, Burton AW, et al. Complex regional pain syndrome: practical diagnostic and treatment guidelines, 4th edition. Pain Med. 2013 Feb. 14(2):180-229. [Medline]. [Full Text].

  16. Rashiq S, Galer BS. Proximal myofascial dysfunction in complex regional pain syndrome: a retrospective prevalence study. Clin J Pain. 1999 Jun. 15(2):151-3. [Medline].

  17. Steverens VL, Oerlemans HM, Weesels A. Cost effectiveness analysis of adjuring physical or occupational therapy for patients with RSD. Arch Phys Med Rehabilitation. 1999. 80:1038-43.

  18. Johnston EC, Howell SJ. Tension neuropathy of the superficial peroneal nerve: associated conditions and results of release. Foot Ankle Int. 1999 Sep. 20(9):576-82. [Medline].

  19. Eckmann MS, Ramamurthy S, Griffin JG. Intravenous regional ketorolac and lidocaine in the treatment of complex regional pain syndrome of the lower extremity: a randomized, double-blinded, crossover study. Clin J Pain. 2011 Mar-Apr. 27(3):203-6. [Medline].

  20. Kumar K, Nath RK, Toth C. Spinal cord stimulation is effective in the management of reflex sympathetic dystrophy. Neurosurgery. 1997 Mar. 40(3):503-8; discussion 508-9. [Medline].

  21. Geurts JW, Smits H, Kemler MA, et al. Spinal cord stimulation for complex regional pain syndrome type I: a prospective cohort study with long-term follow-up. Neuromodulation. 2013 Nov-Dec. 16(6):523-9; discussion 529. [Medline].

  22. van Hilten BJ, van de Beek WJ, Hoff JI, et al. Intrathecal baclofen for the treatment of dystonia in patients with reflex sympathetic dystrophy. N Engl J Med. 2000 Aug 31. 343(9):625-30. [Medline]. [Full Text].

  23. Lundborg C, Dahm P, Nitescu P, et al. Clinical experience using intrathecal (IT) bupivacaine infusion in three patients with complex regional pain syndrome type I (CRPS-I). Acta Anaesthesiol Scand. 1999 Jul. 43(6):667-78. [Medline].

  24. Dielissen PW, Claassen AT, Veldman PH, Goris RJ. Amputation for reflex sympathetic dystrophy. J Bone Joint Surg Br. 1995 Mar. 77(2):270-3. [Medline]. [Full Text].

  25. Monti DA, Herring CL, Schwartzman RJ, et al. Personality assessment of patients with complex regional pain syndrome type I. Clin J Pain. 1998 Dec. 14(4):295-302. [Medline].

  26. Hassenbusch SJ, Stanton-Hicks M, Schoppa D, et al. Long-term results of peripheral nerve stimulation for reflex sympathetic dystrophy. J Neurosurg. 1996 Mar. 84(3):415-23. [Medline].

  27. Zollinger PE, Tuinebreijer WE, Breederveld RS, et al. Can vitamin C prevent complex regional pain syndrome in patients with wrist fractures? A randomized, controlled, multicenter dose-response study. J Bone Joint Surg Am. 2007 Jul. 89(7):1424-31. [Medline].

  28. Mbizvo GK, Nolan SJ, Nurmikko TJ, et al. Placebo Responses in Long-Standing Complex Regional Pain Syndrome: A Systematic Review and Meta-Analysis. J Pain. 2015 Feb. 16(2):99-115. [Medline].

  29. Hsu ES. Practical management of complex regional pain syndrome. Am J Ther. 2009 Mar-Apr. 16(2):147-54. [Medline].

  30. Quang-Cantagrel ND, Wallace MS, Magnuson SK. Opioid substitution to improve the effectiveness of chronic noncancer pain control: a chart review. Anesth Analg. 2000 Apr. 90(4):933-7. [Medline]. [Full Text].

  31. Rowbotham M, Harden N, Stacey B, et al. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA. 1998 Dec 2. 280(21):1837-42. [Medline].

  32. Jain KK. An evaluation of intrathecal ziconotide for the treatment of chronic pain. Expert Opin Investig Drugs. 2000 Oct. 9(10):2403-10. [Medline].

  33. Kiefer RT, Rohr P, Ploppa A, et al. Complete recovery from intractable complex regional pain syndrome, CRPS-type I, following anesthetic ketamine and midazolam. Pain Pract. 2007 Jun. 7(2):147-50. [Medline].

  34. Koffler SP, Hampstead BM, Irani F, et al. The neurocognitive effects of 5 day anesthetic ketamine for the treatment of refractory complex regional pain syndrome. Arch Clin Neuropsychol. 2007 Aug. 22(6):719-29. [Medline].

  35. Dumitru D. Reflex sympathetic dystrophy. Phys Med Rehabil: State Art Rev. 1991. 5:89-101.

  36. Baron R. Peripheral neuropathic pain: from mechanisms to symptoms. Clin J Pain. 2000 Jun. 16(2 Suppl):S12-20. [Medline].

  37. Baron R, Maier C. Reflex sympathetic dystrophy: skin blood flow, sympathetic vasoconstrictor reflexes and pain before and after surgical sympathectomy. Pain. 1996 Oct. 67(2-3):317-26. [Medline].

  38. Bhatia KP, Bhatt MH, Marsden CD. The causalgia-dystonia syndrome. Brain. 1993 Aug. 116 ( Pt 4):843-51. [Medline].

  39. Blanchard J, Ramamurthy S, Walsh N, et al. Intravenous regional sympatholysis: a double-blind comparison of guanethidine, reserpine, and normal saline. J Pain Symptom Manage. 1990 Dec. 5(6):357-61. [Medline].

  40. Brown DL. Somatic or sympathetic block for reflex sympathetic dystrophy. Which is indicated?. Hand Clin. 1997 Aug. 13(3):485-97. [Medline].

  41. Bruehl S, Harden RN, Galer BS, et al. External validation of IASP diagnostic criteria for Complex Regional Pain Syndrome and proposed research diagnostic criteria. International Association for the Study of Pain. Pain. 1999 May. 81(1-2):147-54. [Medline].

  42. Clinchot DM, Lorch F. Sympathetic skin response in patients with reflex sympathetic dystrophy. Am J Phys Med Rehabil. 1996 Jul-Aug. 75(4):252-6.

  43. Cohen JS. Erythromelalgia: new theories and new therapies. J Am Acad Dermatol. 2000 Nov. 43(5 Pt 1):841-7. [Medline].

  44. Davis MD, O''Fallon WM, Rogers RS 3rd, Rooke TW. Natural history of erythromelalgia: presentation and outcome in 168 patients. Arch Dermatol. 2000 Mar. 136(3):330-6. [Medline]. [Full Text].

  45. Galer BS, Bruehl S, Harden RN. IASP diagnostic criteria for complex regional pain syndrome: a preliminary empirical validation study. International Association for the Study of Pain. Clin J Pain. 1998 Mar. 14(1):48-54. [Medline].

  46. Goldstein DJ, Lu Y, Detke MJ, et al. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain. 2005 Jul. 116(1-2):109-18. [Medline].

  47. Harden RN. A clinical approach to complex regional pain syndrome. Clin J Pain. 2000 Jun. 16(2 Suppl):S26-32. [Medline].

  48. Hewitt DJ. The use of NMDA-receptor antagonists in the treatment of chronic pain. Clin J Pain. 2000 Jun. 16(2 Suppl):S73-9. [Medline].

  49. Hopp J, Schwartzman RJ, Grothusen J. Increased sensory thresholds in patients with reflex sympathetic dystrophy. Neurology. Feb 1996. 46 A:227.

  50. Hord ED, Oaklander AL. Complex regional pain syndrome: a review of evidence-supported treatment options. Curr Pain Headache Rep. 2003 Jun. 7(3):188-96. [Medline].

  51. Kemler MA, Barendse GA, van Kleef M, et al. Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. N Engl J Med. 2000 Aug 31. 343(9):618-24. [Medline]. [Full Text].

  52. Kemler MA, van de Vusse AC, van den Berg-Loonen EM, et al. HLA-DQ1 associated with reflex sympathetic dystrophy. Neurology. 1999 Oct 12. 53(6):1350-1. [Medline].

  53. Kingery WS. A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes. Pain. 1997 Nov. 73(2):123-39. [Medline].

  54. Kurvers HA, Jacobs MJ, Beuk RJ, et al. Reflex sympathetic dystrophy: evolution of microcirculatory disturbances in time. Pain. 1995 Mar. 60(3):333-40. [Medline].

  55. Linson MA, Leffert R, Todd DP. The treatment of upper extremity reflex sympathetic dystrophy with prolonged continuous stellate ganglion blockade. J Hand Surg [Am]. 1983 Mar. 8(2):153-9. [Medline].

  56. Merskey H, Bogduk N. Classification of Chronic Pain, Description of Chronic Pain Syndrome and Definitions of Pain Terms. Seattle, Wash: IASP Press; 1994.

  57. Norton JV, Zager E, Grady JF. Erythromelalgia: diagnosis and classification. J Foot Ankle Surg. 1999 May-Jun. 38(3):238-41. [Medline].

  58. Ochoa JL. Reflex sympathetic dystrophy: a disease of medical understanding. Clin J Pain. 1992 Dec. 8(4):363-6; discussion 367-9. [Medline].

  59. Pak TJ, Martin GM, Magness JL, et al. Reflex sympathetic dystrophy. Review of 140 cases. Minn Med. 1970 May. 53(5):507-12. [Medline].

  60. Portenoy RK, Foley KM. Chronic use of opioid analgesics in non-malignant pain: report of 38 cases. Pain. 1986 May. 25(2):171-86. [Medline].

  61. Rommel O, Tegenthoff M, Pern U, et al. Sympathetic skin response in patients with reflex sympathetic dystrophy. Clin Auton Res. 1995 Sep. 5(4):205-10. [Medline].

  62. Schwartzman RJ. Explaining reflex sympathetic dystrophy. Arch Neurol. 1999 May. 56(5):521-2. [Medline].

  63. Schwartzman RJ. New treatments for reflex sympathetic dystrophy. N Engl J Med. 2000 Aug 31. 343(9):654-6. [Medline].

  64. Schwartzman RJ, Kerrigan J. The movement disorder of reflex sympathetic dystrophy. Neurology. 1990 Jan. 40(1):57-61. [Medline].

  65. Schwartzman RJ, Liu JE, Smullens SN, et al. Long-term outcome following sympathectomy for complex regional pain syndrome type 1 (RSD). J Neurol Sci. 1997 Sep 10. 150(2):149-52. [Medline].

  66. Schwartzman RJ, Maleki J. Postinjury neuropathic pain syndromes. Med Clin North Am. 1999 May. 83(3):597-626. [Medline].

  67. Stanton-Hicks M, Baron R, Boas R, et al. Complex regional pain syndromes: guidelines for therapy. Clin J Pain. 1998 Jun. 14(2):155-66. [Medline].

  68. Stanton-Hicks M, Janig W, Hassenbusch S, et al. Reflex sympathetic dystrophy: changing concepts and taxonomy. Pain. 1995 Oct. 63(1):127-33. [Medline].

  69. Tahmoush AJ, Schwartzman RJ, Hopp JL, et al. Quantitative sensory studies in complex regional pain syndrome type 1/RSD. Clin J Pain. 2000 Dec. 16(4):340-4. [Medline].

  70. van der Laan L, Veldman PH, Goris RJ. Severe complications of reflex sympathetic dystrophy: infection, ulcers, chronic edema, dystonia, and myoclonus. Arch Phys Med Rehabil. 1998 Apr. 79(4):424-9. [Medline].

  71. Wasner G, Backonja MM, Baron R. Traumatic neuralgias: complex regional pain syndromes (reflex sympathetic dystrophy and causalgia): clinical characteristics, pathophysiological mechanisms and therapy. Neurol Clin. 1998 Nov. 16(4):851-68. [Medline].

  72. Wechsler RJ, Frank ED, Halpern EH, et al. Percutaneous lumbar sympathetic plexus catheter placement for short- and long-term pain relief: CT technique and results. J Comput Assist Tomogr. 1998 Jul-Aug. 22(4):518-23. [Medline].

  73. Wilder RT, Berde CB, Wolohan M, et al. Reflex sympathetic dystrophy in children. Clinical characteristics and follow-up of seventy patients. J Bone Joint Surg Am. 1992 Jul. 74(6):910-9. [Medline].

  74. Zollinger PE, Tuinebreijer WE, Kreis RW, et al. Effect of vitamin C on frequency of reflex sympathetic dystrophy in wrist fractures: a randomised trial. Lancet. 1999 Dec 11. 354(9195):2025-8. [Medline].

 
Previous
Next
 
A 29-year-old woman with reflex sympathetic dystrophy in the right foot demonstrates discoloration of the skin and marked allodynia.
This photo shows the same patient as in the above image, following a right lumbar sympathetic block. Marked increase in the temperature of the right foot is noted, with more than 50% pain relief.
A 68-year-old woman with complex regional pain syndrome type II (causalgia).
A 36-year-old woman with right arm reflex sympathetic dystrophy and dystonic posture (movement disorder).
Normal laser Doppler study of the upper extremities. When the patient performs inspiratory gasp repeatedly during laser Doppler image acquisition, the transient capillary flow decreases are displayed easily and dramatically (as dark bands) in the pseudocolor image.
Laser Doppler study of the upper extremities in a patient with right hand reflex sympathetic dystrophy.
Laser Doppler study of the lower extremities in a 25-year-old woman with reflex sympathetic dystrophy in the right foot.
Algorithm for the management of chronic regional pain syndrome (CRPS). Resolution of this syndrome does not commonly occur, and the patient will need chronic pain management.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.